financetom
Business
financetom
/
Business
/
Here's how much the top bosses of major Indian companies are earning
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Here's how much the top bosses of major Indian companies are earning
Jun 14, 2019 3:27 AM

Here's how much the top bosses of major Indian companies are earning

SUMMARY

Top Indian companies have declared the annual pay packages of their CEOs. Here's a list of the top bosses of major Indian companies with their incomes, as released in the firms' annual reports and exchange filings.

By CNBC-TV18Aug 9, 2019 12:50:51 PM IST (Updated)

Rajesh Gopinathan, Tata Consultancy Services CEO, took home a pay package of over Rs 16 crore in FY19, an increase of almost 28 percent compared to the previous fiscal. Gopinathan's compensation included Rs 1.15 crore in salary, Rs 1.26 crore in perquisites, Rs 13 crore in commission and over Rs 60 lakh in other allowances.

Salil Parekh, Infosys CEO, took home a pay package of Rs 24.67 crore in FY19. He received Rs 6.07 crore in fixed salary, Rs 10.96 crore in bonus, incentives and variable pay and Rs 7.64 crore in perquisites on account of exercise of 1,03,604 restricted stock units (RSUs) during the FY.

In a regulatory filing, Wipro said Abidali Neemuchwala’s salary jumped nearly 41 percent to $3.95 million (approx Rs 27 crore) in FY19, with variable pay forming a large chunk as it is paid to him annually.

The newly-appointed CEO and MD of Yes Bank, Ravneet Gill, will get a salary of Rs 6 crore per year, apart from perquisites and employee stock options worth Rs 67.50 lakh. Gill was officially appointed on January 24, 2019, replacing founder Rana Kapoor. (stock image)

ITC Chairman & MD Sanjiv Puri's package has gone up by over 51 percent to Rs 6.16 crore in 2018-19. Puri had a takehome salary of Rs 4.06 crore in FY 2017-18.

Asian Paints MD KBS Anand took home a total remuneration of Rs 11.8 crore in FY19. His salary nearly doubled from Rs 6.1 crore in five years.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stock exchange operator TMX's Q3 revenue beats estimates on strong derivatives trading
Stock exchange operator TMX's Q3 revenue beats estimates on strong derivatives trading
Oct 27, 2025
Overview * TMX Group ( TMXXF ) Q3 revenue rises 18% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong operational performance * TMX Group ( TMXXF ) completes acquisition of Verity Outlook * TMX Group ( TMXXF ) focuses on accelerating growth and delivering shareholder value in 2025 * Company highlights strategic focus on global...
GlobalFoundries finance chief John Hollister departs, Sam Franklin named interim CFO
GlobalFoundries finance chief John Hollister departs, Sam Franklin named interim CFO
Oct 27, 2025
Oct 27 (Reuters) - GlobalFoundries' ( GFS ) John Hollister has stepped down from the CFO position and will be succeeded by Sam Franklin on an interim basis, the contract chipmaker said on Monday. The management reshuffle comes at a time when the company has pledged to invest $16 billion partly towards building more manufacturing facilities on American soil amid...
GlobalFoundries finance chief John Hollister departs, Sam Franklin named interim CFO
GlobalFoundries finance chief John Hollister departs, Sam Franklin named interim CFO
Oct 27, 2025
(Reuters) -GlobalFoundries' ( GFS ) John Hollister has stepped down from the CFO position and will be succeeded by Sam Franklin on an interim basis, the contract chipmaker said on Monday. The management reshuffle comes at a time when the company has pledged to invest $16 billion partly towards building more manufacturing facilities on American soil amid U.S. President Donald...
Australia's CSL delays vaccine division spin-off amid US market volatility
Australia's CSL delays vaccine division spin-off amid US market volatility
Oct 27, 2025
Oct 28 (Reuters) - Australian biotech CSL said on Tuesday it was no longer targeting to complete the spin-off of its vaccine division in fiscal 2026, citing heightened volatility in the U.S. influenza vaccine market. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved